Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Cardiovasc Transl Res. 2015 Jul 21;8(8):475–483. doi: 10.1007/s12265-015-9644-2

Table 1.

Validation results per prevalence of the disease in each population

*Estimated
prevalence of
heart failure
Positive
predictive
value		 Negative
predictive
value		 Sensitivity Specificity
Mayo Genome Consortia (MayoGC)/eMERGE 6.2% 0.94 0.98 0.71 0.99
Group Health 10.1% 0.80 1.0 1.0 0.97
*

Estimated prevalence based on Go, A.S., Mozaffarian, D., Roger, V.L., et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129, e28–e292 corresponding to the sex averaged rates for 60–79 year olds for MayoGC/eMERGE and the 80+ year olds for Group Health.